3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Anatomic Stage III Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Renal Insufficiency, Chronic
1
Prostatic Neoplasms
1
Pleuropulmonary blastoma
1
Pain
1
Neuroblastoma
1
Melanoma
1
Leukemia, Hairy Cell
1
Ganglioneuroblastoma
1
Carcinoma, Renal Cell
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Interventions
Cyclophosphamide
12
Vincristine
9
Etoposide
8
venetoclax
6
Methotrexate
6
Doxorubicin
6
Dexamethasone
6
Cytarabine
6
Prednisone
5
Calcium Dobesilate
5
prednylidene
4
pegaspargase
4
merphos
4
dexamethasone acetate
4
dexamethasone 21-phosphate
4
deltacortene
4
calaspargase pegol
4
auricularum
4
Specimen Handling
4
Granulocyte Colony-Stimulating Factor
4
fludarabine phosphate
3
daratumumab
3
Thioguanine
3
Rituximab
3
Peripheral Blood Stem Cell Transplantation
3
Mercaptopurine
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Hydrocortisone
3
Filgrastim
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
×
High-Energy Shock Waves
×
90 days
×
Clear all
No trials found.